PeproTech Inc.

This Article
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rollo, E. E.
Right arrow Articles by Denhardt, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rollo, E. E.
Right arrow Articles by Denhardt, D. T.

Journal of Leukocyte Biology, Vol 60, Issue 3 397-404, Copyright © 1996 by Society for Leukocyte Biology


JOURNAL ARTICLE

Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages

EE Rollo, DL Laskin and DT Denhardt
Department of Biological Sciences, Rutgers University, Piscataway, New Jersey 08855, USA.

Osteopontin (OPN), a secreted acidic phosphoglycoprotein found in many tissues and body fluids, is produced in increased amounts in response to certain infections and after malignant transformation. In this study we examined the action of OPN on macrophage cytotoxicity and nitric oxide (NO) synthesis. A human OPN cDNA was cloned into the bacteriophage T7-based vector, pET8C, and the encoded protein purified from an induced culture of Escherichia coli carrying the plasmid. Recombinant OPN inhibited NO production by macrophage-like RAW264.7 cells stimulated with lipopolysaccharide plus interferon-gamma. OPN also inhibited the cytolytic activity of the activated macrophages toward NO-sensitive P815 mastocytoma cells, an action that was blocked by the NO synthase inhibitor, NG-monomethyl-L-arginine. Inhibition of NO production correlated with an OPN-dependent decrease in the abundance of inducible NO synthase mRNA. The shape of the dose-response curve, with a maximal effect over a narrow range of OPN concentrations, suggested a complex interaction of OPN with cell surface receptors. Our data support the hypothesis that tumor-cell-derived OPN functions to protect the tumor cells from macrophage-mediated destruction.


This article has been cited by other articles:


Home page
IOVSHome page
G. Chidlow, J. P. M. Wood, J. Manavis, N. N. Osborne, and R. J. Casson
Expression of Osteopontin in the Rat Retina: Effects of Excitotoxic and Ischemic Injuries
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 762 - 771.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. R. Rodrigues, J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson
The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1087 - 1097.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. A. Arafat, A. K. Katakam, G. Chipitsyna, Q. Gong, A. R. Vancha, J. Gabbeta, and D. C. Dafoe
Osteopontin Protects the Islets and {beta}-Cells from Interleukin-1 {beta}-Mediated Cytotoxicity through Negative Feedback Regulation of Nitric Oxide
Endocrinology, February 1, 2007; 148(2): 575 - 584.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
J. Sodek, A. P. Batista Da Silva, and R. Zohar
Osteopontin and Mucosal Protection
Journal of Dental Research, May 1, 2006; 85(5): 404 - 415.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Minoretti, C. Falcone, M. Calcagnino, E. Emanuele, M. P. Buzzi, E. Coen, and D. Geroldi
Prognostic significance of plasma osteopontin levels in patients with chronic stable angina
Eur. Heart J., April 1, 2006; 27(7): 802 - 807.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A K Katakam, G Chipitsyna, Q Gong, A R Vancha, J Gabbeta, and H A Arafat
Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production
J. Endocrinol., November 1, 2005; 187(2): 237 - 247.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. E. Rollo, S. J. Hempson, A. Bansal, E. Tsao, I. Habib, S. R. Rittling, D. T. Denhardt, E. R. Mackow, and R. D. Shaw
The Cytokine Osteopontin Modulates the Severity of Rotavirus Diarrhea
J. Virol., March 15, 2005; 79(6): 3509 - 3516.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Gao, H. Guo, J. Wei, Z. Mi, P. Wai, and P. C. Kuo
S-Nitrosylation of Heterogeneous Nuclear Ribonucleoprotein A/B Regulates Osteopontin Transcription in Endotoxin-stimulated Murine Macrophages
J. Biol. Chem., March 19, 2004; 279(12): 11236 - 11243.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. Li, C. W. Yang, W. Y. Kim, J. Y. Jung, J. H. Cha, Y. S. Kim, J. Kim, W. M. Bennett, and B. K. Bang
Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine
Am J Physiol Renal Physiol, February 1, 2003; 284(2): F389 - F398.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
M. Mazzali, T. Kipari, V. Ophascharoensuk, J.A. Wesson, R. Johnson, and J. Hughes
Osteopontin--a molecule for all seasons
QJM, January 1, 2002; 95(1): 3 - 13.
[Full Text] [PDF]


Home page
J. Immunol.Home page
H. Guo, C. Q. Cai, R. A. Schroeder, and P. C. Kuo
Osteopontin Is a Negative Feedback Regulator of Nitric Oxide Synthesis in Murine Macrophages
J. Immunol., January 15, 2001; 166(2): 1079 - 1086.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. M. BONVINI, U. SCHATZMANN, B. BECK-SCHIMMER, L. K. SUN, S. R. RITTLING, D. T. DENHARDT, M. LE HIR, and R. P. WÜTHRICH
Lack of In Vivo Function of Osteopontin in Experimental Anti-GBM Nephritis
J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1647 - 1655.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. A. Kreidberg and J. M. Symons
Integrins in kidney development, function, and disease
Am J Physiol Renal Physiol, August 1, 2000; 279(2): F233 - F242.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Nemir, D. Bhattacharyya, X. Li, K. Singh, A. B. Mukherjee, and B. B. Mukherjee
Targeted Inhibition of Osteopontin Expression in the Mammary Gland Causes Abnormal Morphogenesis and Lactation Deficiency
J. Biol. Chem., January 14, 2000; 275(2): 969 - 976.
[Abstract] [Full Text] [PDF]


Home page
CROBMHome page
J. Sodek, B. Ganss, and M.D. McKee
Osteopontin
Critical Reviews in Oral Biology & Medicine, January 1, 2000; 11(3): 279 - 303.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
R. Kuykindoll, H Nishimura, D. Thomason, and S. Nishimoto
Osteopontin expression in spontaneously developed neointima in fowl (Gallus gallus)
J. Exp. Biol., January 1, 2000; 203(2): 273 - 282.
[Abstract] [PDF]


Home page
Infect. Immun.Home page
G. J. Nau, L. Liaw, G. L. Chupp, J. S. Berman, B. L. M. Hogan, and R. A. Young
Attenuated Host Resistance against Mycobacterium bovis BCG Infection in Mice Lacking Osteopontin
Infect. Immun., August 1, 1999; 67(8): 4223 - 4230.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Scott, M. L. Weir, S. M. Wilson, J. W. Xuan, A. F. Chambers, and D. G. McCormack
Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue
Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2258 - H2265.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X. Wang, C. Louden, T.-L. Yue, J. A. Ellison, F. C. Barone, H. A. Solleveld, and G. Z. Feuerstein
Delayed Expression of Osteopontin after Focal Stroke in the Rat
J. Neurosci., March 15, 1998; 18(6): 2075 - 2083.
[Abstract] [Full Text] [PDF]